Jelena Đoković

Jelena Đoković was born on March 7th, 1991 in Ivanjica, where she finished elementary and high school, gaining ,,Vuk Karadžić’’ diplomas. She graduated from the Faculty of pharmacy, University of Belgrade in 2015. During her undergraduate studies she was awarded scholarships from the Republic of Serbia’s Ministry of Education and Sports and the Foundation for young talents. After completing her internship she passed the pharmacist licensing exam in 2016. She began her PhD studies in pharmaceutical technology in 2016 at the Faculty of pharmacy, University of Belgrade.

She participates in realization of practical courses in Pharmaceutical technology 1 and Pharmaceutical technology 2 at the Department of pharmaceutical technology and cosmetology. During her doctoral studies she completed several research stays abroad, at the: Faculty of pharmacy, Medical university of Gdansk, Eberhard-Karls University in Germany National Hellenic Research Foundation in Athens and at the Institute of Pharmaceutical Technology and European Commission's Nanobiotechnology Laboratory in Italy.

Currently she is working as a researcher on the H2020 Neurotoxicity De-Risking in Preclinical Drug Discovery (NeuroDeRisk) project, as well as the IDEA’s project Neuroimmune aspects of mood, anxiety and cognitive effects of leads/drug candidates acting at GABAA and/or sigma-2 receptors: In vitro/in vivo delineation by nano- and hiPSC-based platform (NanoCellEmoCog).

She is author/co-author of 4 peer reviewed scientific publications in high ranking international journals. Research interests: development, physicochemical and in vivo characterization of nanorformulations for different administration routes.

• Đoković J. B., Savić S. M., Mitrović J. R., Nikolic I., Marković B. D., Randjelović D. V., Antic-Stankovic J., Božić D., Cekić N. D., Stevanović V., Batinić B., Aranđelović J., Savić M., M., Savić, S. D. (2021). Curcumin loaded pegylated nanoemulsions designed for maintained antioxidant effects and improved bioavailability: A pilot study on rats. International journal of molecular sciences, 22(15), 7991.

• Mitrović J. R., Divović-Matović B., Knutson D. E., Đoković J. B., Kremenović A., Dobričić V. D., Dobričić V. D., Randjelović D. V., Pantelić I., Cook J. M., Savić M. M., Savić, S. D. (2021). Overcoming the low oral bioavailability of deuterated pyrazoloquinolinone ligand dk-i-60-3 by nanonization: A knowledge-based approach. Pharmaceutics, 13(8), 1188.
• Mitrović J. R., Divović B., Knutson D. E., Đoković J. B., Vulić P. J., Randjelović D. V., Dobričić V. D., Čalija B. R., Cook J. M., Savić M. M., Savić S. D. (2020). Nanocrystal dispersion of DK-I-56–1, a poorly soluble pyrazoloquinolinone positive modulator of α6 GABAA receptors: Formulation approach toward improved in vivo performance. European Journal of Pharmaceutical Sciences, 152, 105432.
• Gledovic A., Janosevic Lezaic A., Krstonosic V., Djokovic J., Nikolic I., Bajuk-Bogdanovic D., Antić Stanković J., Randjelovic D. Savic S. M., Tamburic S., Savic S. D. (2020). Low-energy nanoemulsions as carriers for red raspberry seed oil: Formulation approach based on Raman spectroscopy and textural analysis, physicochemical properties, stability and in vitro antioxidant/biological activity. Plos one, 15(4), e0230993